Please login to the form below

Not currently logged in
Email:
Password:

bacterial resistance

This page shows the latest bacterial resistance news and features for those working in and with pharma, biotech and healthcare.

GSK takes new-class antibiotic into phase 3 for serious infections

GSK takes new-class antibiotic into phase 3 for serious infections

Because it works in a different way to any currently-approved antibiotic, gepotidacin could sidestep bacterial resistance mechanisms. ... EAGLE-1 will compare gepotidacin – a triazaacenaphthylene bacterial topoisomerase inhibitor developed in

Latest news

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Tackling antimicrobial resistance on multiple fronts Tackling antimicrobial resistance on multiple fronts

    With an estimated 25, 000 deaths in Europe alone and one person dying every 15 minutes in the US because of drug-resistant bacterial infections, antimicrobial resistance (AMR) is undoubtedly one ... latest World Bank report, Pulling Together to Beat

  • The impending threat of antibiotic resistance The impending threat of antibiotic resistance

    The frequency of antibiotic resistance in a bacterial culture is in the order of one antibiotic resistant mutation in 100 million bacteria. ... Combining two existing antibiotics to see if they can overcome antibiotic resistance or.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....